Current Edition

Screenshot 2017-07-27 10.35.26
Clinical Research

HCP Engagement in a Multichannel World: Why Quality Customer Data is Critical

Quality customer data is foundational to commercial operations, and yet most European life sciences companies are not getting what they need from their customer data. …

Continue Reading →
Screenshot 2017-07-27 10.31.35
Clinical Research

Technology Assisted Cohort Optimisation of Early-phase Multi-centre Patient Studies

The common aims of early-phase research centre around helping to define the safety, tolerability and pharmacokinetics of a drug at single or multiple doses (or …

Continue Reading →
Screenshot 2017-07-27 10.24.11
Clinical Research

Four Easy Steps to Site Optimisation

To Get the Most Out of Investigative Sites, Go After the Low-hanging Fruit In today’s clinical development arena, clinical trial sponsors are expected to achieve …

Continue Reading →
Screenshot 2017-07-27 10.17.39
Drug Discovery, Development and Delivery

Achieving Agility: Real Breakthroughs Belong to the Bold

As the old adage goes, if you keep doing the same things it can’t come as a surprise when the outcome doesn’t improve. Organising data …

Continue Reading →
Screenshot 2017-07-27 09.58.38
Drug Discovery, Development and Delivery

DSC: A Sensitive Tool for Comparing the Stability of Biosimilars

Growth forecasts for the global biopharmaceuticals market vary, but headline figures of close to USD 300 billion by the year 2021, rising from an estimated …

Continue Reading →
Screenshot 2017-07-26 16.34.56
Editorial Archive

Navigation of Key Regulatory Information for Efficient Life-cycle Management of Regulated Product and Application in SINGAPORE

Developing an innovative healthcare product (a drug or a biologic, or a medical device) from the proof-of- concept stage to the marketing stage is an …

Continue Reading →
Screenshot 2017-07-26 16.19.30
Editorial Archive

CpG OligonucleotideTherapeutics– A History Lesson for CRISPR?

When we look at the emerging and likely future battles being fought to establish dominance in the emerging field of CRISPR technologies, it may be …

Continue Reading →
NE4
Editorial Archive

The North of England – An Internationally Recognised Health and Life Science Ecosystem

The North of England’s profile as a hub of health science has been on an impressive trajectory over the past five years. With some of …

Continue Reading →
Screenshot 2017-07-26 15.45.54
Editorial Archive

Safety and Regulatory Solutions to Address the Needs of Small and Medium Biopharmaceutical Companies

Small and medium-sized enterprises (SMEs) are often faced with the challenge of having limited resources which can impact their ability to seamlessly move products through …

Continue Reading →
Screenshot 2017-07-26 15.35.50
Editorial Archive

Change Management

The life sciences industry is currently facing unprecedented turmoil. Peter Muller of Schlafender Hase outlines five trends pharma companies will need to weather in 2017, …

Continue Reading →